Shark Lipids for Treatment of Malignant Diseases

Annual Meeting of Korean Society of Cancer prevention 2005

Shark Lipids for Treatment of Malignant Diseases

Satoru Furukawa
Heimat Co., Ltd, Tokyo, Japan

Integrated medication should be considered more seriously for treatment of malignant diseases such as cancer. The Second Complimentary and Alternative/Integrated Medicine Forum had been held at Akihabara Convention Center in Tokyo in November 12 2005, sponsored by a newly established NPO “Association for Life Style Related Diseases and Integrated Medicine”.

Lipid fraction extracted from shark muscle came under the spotlight because of its unique biological functions. Dr. P. Davis, the University of Otago in New Zealand, and Prof. K-Y. Park, Pusan National University, presented the research history and mechanism of anti-angiogenic activities of shark lipids extract.

Prof. W. Koestler, president of the Austrian Society of Oncology, presented clinical data of significant effects of shark lipids in combination with other health food supplement on QOL of very advanced cancer patients. Dr. O. Mizukami at Tokyo Adventist Hospital, who has been using shark lipids product for his cancer patients, explained importance of integrative medicine. Dr. S. Grekin, Michigan State University, presented clinical benefits of shark lipids for psoriasis patients.

Potential application of shark lipids extract for malignant disease will be presented using clinical case reports in EU, US and Japan.

Research
  • The effectiveness of bovine IgG fraction against salmonella, O-157 and non-tuberculous mycobacteria
    Enriched bovine IgG fraction prevents infections with Enterohaemorrhagic Escherichia coli O157:H7, Salmonella enterica serovar Enteritidis, and Mycobacterium avium

  • New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma

  • Red pigment from Saw palmetto: A natural product for potential alternative cancer treatment

  • CBP Facilitate Osteogenesis through Activation of the JNK-ATF4 Pathway
    CBP Facilitate Osteogenesis through Activation of the JNK-ATF4 Pathway

  • CBP increases Bone Mineral Density
    Concentrated-Bovine protein (CBP) increases Bone Mineral Density

  • Effect of a Growth Protein-Colostrum Fraction on Bone Development in Juvenile Rats
    Effect of a Growth Protein-Colostrum Fraction on Bone Development in Juvenile Rats

  • Effects of Colostrum Basic Protein from Colostrum Whey Protein: Increased in Osteoblast Proliferation and Bone Metabolism

  • An Ethanolic extract from a shark having potent anti-angiogenic activity: its anti-angiogenic mechanism and clinical application

  • Shark Lipids for Treatment of Malignant Diseases

  • Inhibition of Cancer Growth and Metastases by Preparations Based on Shark Oil

  • Leptin Stimulates Ischemia-Induced Retinal Neovascularization
    Leptin Stimulates Ischemia-Induced Retinal Neovascularization

  • Angiogenesis in an in vivo model of adipose tissue development
    Angiogenesis in an in vivo model of adipose tissue development

  • The effects of functional foods, such as Agaricus, Pleurotus cornucopiae (Paulet) Rolland var. citrinopileatus (Sing.) Ohira. , Hericium erinaceum, Arabinoxylan, Shark cartilage and Shark extracted lipid on growth of implanted Mouse LM8 Dunn osteosarcoma

  • Targeted Overexpression of the Angiogenesis Inhibitor in the Epidermis Prevents Ultraviolet-B-Induced Angiogenesis and Cutaneous Photo-Damage
    Targeted Overexpression of the Angiogenesis Inhibitor Thrombospondin-1 in the Epidermis of Transgenic Mice Prevents Ultraviolet-B-Induced Angiogenesis and Cutaneous Photo-Damage